Efficacy and safety of tongxinluo capsule for angina pectoris of coronary heart disease: an overview of systematic reviews and meta-analysis

BackgroundTongxinluo capsule (TXLC) is a common drug for treating angina pectoris of coronary heart disease (CHD). In recent years, many systematic reviews (SRs) and meta-analyses (MAs) have reported the efficacy and safety of TXLC for improving angina symptoms in patients with CHD. We aimed to comp...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Liuying Li, Peimin Feng, Wenhua Zhou, Biao Luo, Lvyu Deng, Daohui Gan, Xiaohan Wu, Fengya Zhu, Xia Zhou
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2024-02-01
סדרה:	Frontiers in Cardiovascular Medicine
נושאים:	tongxinluo capsule angina pectoris coronary heart disease overview traditional Chinese medicine
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1229299/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!